Literature DB >> 6218091

Leishmaniasis in beige mice.

C E Kirkpatrick, J P Farrell.   

Abstract

The courses of two protozoal diseases, cutaneous and visceral leishmaniasis, were examined in three groups of C57BL/6J mice. One group of mice was homozygous recessive for the beige gene (bg/bg). Beige mice are the genetic homologue of the human Chédiak-Higashi syndrome and, among other defects, are profoundly deficient in natural killer cell activity. Wild-type (+/+) mice, which respond to experimental cutaneous or visceral leishmaniasis by eventually eliminating their parasites, and heterozygous beige (bg/+) mice served as controls; both are phenotypically normal in natural killer cell activity, which is particularly high in the spleen. In bg/bg mice, the course of Leishmania tropica, a causative agent of cutaneous leishmaniasis, was similar to that in control mice after both primary and challenge inoculations. All groups of mice expressed similar humoral and cellular immune responses to L. tropica antigen. However, bg/bg mice failed to eliminate amastigotes of Leishmania donovani, a causative agent of visceral leishmaniasis, from their spleens over an observation period of 56 days, in contrast to bg/+ and +/+ controls. Similar levels of anti-leishmanial antibody were produced by all groups of mice, and all mice responded comparably to footpad injections of L. donovani antigen. The results of this study suggest a possible role for natural killer cells in recovery from L. donovani but not from L. tropica infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218091      PMCID: PMC347877          DOI: 10.1128/iai.38.3.1208-1216.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect.

Authors:  J C Roder; M L Lohmann-Matthes; W Domzig; H Wigzell
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

2.  Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana-infected macrophages.

Authors:  J Alexander; K Vickerman
Journal:  J Protozool       Date:  1975-11

3.  The beige mutation in the mouse selectively impairs natural killer cell function.

Authors:  J Roder; A Duwe
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

4.  The resistance of intracellular Leishmania parasites to digestion by lysosomal enzymes.

Authors:  D H Lewis; W Peters
Journal:  Ann Trop Med Parasitol       Date:  1977-09

5.  Characterization of strains of Leishmania donovani.

Authors:  L A Stauber
Journal:  Exp Parasitol       Date:  1966-02       Impact factor: 2.011

6.  The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function.

Authors:  J C Roder
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

7.  Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.

Authors:  E Handman; R Ceredig; G F Mitchell
Journal:  Aust J Exp Biol Med Sci       Date:  1979-02

8.  Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.

Authors:  D J Bradley; J Kirkley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

9.  Infection and immunoglobulin concentrations in Chediak-Higashi mice.

Authors:  R J Elin; J B Edelin; S M Wolff
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

10.  Leishmania donovani. Hamster macrophage interactions in vitro: cell entry, intracellular survival, and multiplication of amastigotes.

Authors:  K P Chang; D M Dwyer
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  21 in total

1.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

2.  Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.

Authors:  Henry W Murray; Marisa Mitchell-Flack; Hua Zheng; Xiaojing Ma
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

3.  Systemic Coccidioides immitis infection in nude and beige mice.

Authors:  K V Clemons; C R Leathers; K W Lee
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

4.  Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.

Authors:  T M Scharton; P Scott
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

5.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

6.  Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Authors:  J Champsi; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

7.  Impairment of natural killer cell activity in Indian kala-azar: restoration of activity by interleukin 2 but not by alpha or gamma interferon.

Authors:  P P Manna; D Bharadwaj; S Bhattacharya; G Chakrabarti; D Basu; K K Mallik; S Bandyopadhyay
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.

Authors:  R T Mehta
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  Effector role of blood monocytes in experimental visceral leishmaniasis.

Authors:  J S Cervia; H Rosen; H W Murray
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

10.  Toxoplasma-induced activities of peritoneal and spleen natural killer cells from beige mice against thymocytes and YAC-1 lymphoma targets.

Authors:  T Kamiyama
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.